Replies to post #259 on Xenoport (f/k/a XNPT)

[ghmm]

Well Acorda just made a small deal for a Phase 1 drug so it appears they are open to compounds not yet approved. Though licensing the Xenoport compound would cost significantly more.

Acorda Therapeutics Licenses Rights to Investigational Treatment for Spinal Cord Injury and Traumatic Brain Injury
http://finance.yahoo.com/news/Acorda-Therapeutics-Licenses-bw-4144382498.html?x=0&.v=1